Search
UK MHRA Guidance: Access Consortium’s New Active Substance Work Sharing Initiative (NASWSI)
The Medicines and Healthcare products Regulatory Agency (MHRA) provides information on the Access Consortium’s New Active Substance Work Sharing Initiative (NASWSI), an international regulatory collaboration that coordinates the assessment of new active substance applications across participating regulatory authorities. The initiative aims to strengthen regulatory cooperation, increase assessment capacity and support timely access to high-quality, safe and effective therapeut
Sharan Murugan
2 hours ago3 min read